Abbreviation (ISO4): Chinese Journal of Alzheimer's Disease and Related Disorders
Editor in chief: Jun WANG
Chinese Journal of Alzheimer's Disease and Related Disorders >
Blood biomarkers of Alzheimer's disease, progress and prediction
Received date: 2019-06-17
Revised date: 2019-06-29
Online published: 2019-09-25
Alzheimer’s disease (AD) is a major neurodegenerative disease that causes dementia in elderly people. The etiology of AD is complicated and its progress is slow in a long period. Therefore, early diagnosis and intervention are important strategies for the prevention and treatment of AD. The classical method for clinical diagnosis of AD is to detect the biomarkers in cerebrospinal fluid (CSF). However, it is very difficult to collect the CSF sample and thus to use this method widely. Meanwhile, those biomarkers in CSF are present at very low levels in blood samples that requires highly sensitive method for the detection. In recent years, the researches of AD biomarkers focus on two aspects: one is to establish new detection methods with high sensitivity and specificity, and the other is to explore and discover some new biomarkers in blood. In this paper, the latest progress of AD biomarkers in human peripheral blood is reviewed briefly, and the possibility of its application in clinical diagnosis is analyzed.
Key words: Alzheimer's disease (AD); Biomarker; Blood; Bioinfbrmatics
XU Qing , YAO Fang , SHEN Liming , NI Jiazuan , LIU Qiong . Blood biomarkers of Alzheimer's disease, progress and prediction[J]. Chinese Journal of Alzheimer's Disease and Related Disorders, 2019 , 2(3) : 444 -449 . DOI: 10.3969/j.issn.2096-5516.2019.03.011
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
/
〈 |
|
〉 |